Frazier Life Sciences Acquisition Corp. II Class A Ordinary Shares

Frazier Life Sciences Acquisition Corp. II Class A Ordinary Shares(FLSC)股票分析

$10.210

+0.010 (+0.10%)收盘时

Loading chart…
最高
10.290
开盘
10.290
成交量加权均价
10.23
成交量
2.53K
市值
—
最低
10.180
成交额
25.88K
企业价值/息税折旧摊销前利润(TTM)
0.00

AI 分析 of Frazier Life Sciences Acquisition Corp. II Class A Ordinary Shares (FLSC)

持有

Frazier Life Sciences Acquisition Corp. II is currently trading at $10.16, which is 25.6% of its 52-week range between $10.00 and $10.62. The stock has shown a year-to-date change of +1.60%, indicating some stability. However, with a lack of significant insider or hedge fund activity and a neutral market context, it may be prudent to hold rather than buy at this time. The main risk is the recent 5-day change of -1.17%, suggesting potential downward momentum.

估值指标

Frazier Life Sciences Acquisition Corp. II Class A Ordinary Shares(FLSC)当前预期市盈率为 0.00,5 年平均预期市盈率为 。

预期市盈率

5 年均值 P/E
当前P/E
0.00

预期 EV/EBITDA

5 年均值 EV/EBITDA
当前EV/EBITDA
0.00

预期市销率

5 年均值 P/S
当前P/S
0.00

FLSC 常见问题 —— 由 Alphio AI 解答

Frazier Life Sciences Acquisition Corp. II is currently trading at $10.16, which is 25.6% of its 52-week range between $10.00 and $10.62. The stock has shown a year-to-date change of +1.60%, indicating some stability. However, with a lack of significant insider or hedge fund activity and a neutral market context, it may be prudent to hold rather than buy at this time. The main risk is the recent 5-day change of -1.17%, suggesting potential downward momentum.

暂无帖子

注册或登录后参与讨论

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易